Dare Bioscience, Inc. Increase (Decrease) in Deferred Liabilities
Dare Bioscience, Inc. (DARE) reported Increase (Decrease) in Deferred Liabilities of $9.32 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2019-04-01
- Dare Bioscience, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-12-31 was $419.00, a 78.30% increase year-over-year.
- Dare Bioscience, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-09-30 was $8.97K, a 203.52% increase year-over-year.
- Dare Bioscience, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-06-30 was -$2.57K.
- Dare Bioscience, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-03-31 was $2.50K.
- Dare Bioscience, Inc. increase (decrease) in deferred liabilities for fiscal 2018 was $9.32K, a 2277.30% increase from fiscal 2017.
- Dare Bioscience, Inc. increase (decrease) in deferred liabilities for fiscal 2017 was $392.00.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2018-12-31 | $419.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $9.39K derived: sum of 2 quarters · filed 2019-04-01 | $6.82K derived: sum of 3 quarters · filed 2019-04-01 | $9.32K 10-K · filed 2019-04-01 |
| 2018-09-30 | $8.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $6.40K derived: sum of 2 quarters · filed 2018-11-13 | $8.90K 10-Q · filed 2018-11-13 | $9.13K derived: sum of 4 quarters · filed 2019-04-01 |
| 2018-06-30 | -$2.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$75.00 10-Q · filed 2018-08-13 | $160.00 derived: sum of 3 quarters · filed 2019-04-01 | $3.12K derived: sum of 4 quarters · filed 2019-04-01 |
| 2018-03-31 | $2.50K 10-Q · filed 2018-05-14 | $2.73K derived: sum of 2 quarters · filed 2019-04-01 | $5.69K derived: sum of 3 quarters · filed 2019-04-01 | |
| 2017-12-31 | $235.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $3.19K derived: sum of 2 quarters · filed 2019-04-01 | $392.00 10-K · filed 2019-04-01 | |
| 2017-09-30 | $2.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $157.00 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$2.80K 10-Q · filed 2018-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |